Robotic Platform Augments Surgeons Capabilities

To use the SurgiBot, the surgeon makes a small, single incision in the patient’s abdomen—often hidden inside the navel—and inserts the device, which opens like an umbrella, extending articulating instrument channels whose strength and precision are controlled by the surgeon’s hands.

The expansion offers multiple channels to the operating site that are capable of accommodating both rigid and flexible articulating instruments. Motorized hand controls provide strength and precision, offering a tactile feel and freedom of movement. High-definition 3D visualization helps restore the depth perception lost in traditional laparoscopic procedures. After completion, the surgeon closes and retracts the device back through the same incision. The SurgiBot is a product of TransEnterix (Research Triangle Park, NC, USA) based on the company’s existing manual surgical platform, the Spider Surgical System, and is undergoing preclinical testing.

“TransEnterix has ‘powered up’ laparoscopy to make it easier for surgeons to complete procedures in the most minimally invasive way possible,” said Todd M. Pope, president and CEO of TransEnterix. “SurgiBot utilizes robotic technologies and techniques to enhance strength, precision, and ergonomic comfort for surgeons.”

“SurgiBot has the opportunity to revolutionize the robotic market,” said Juan-Carlos Verdeja, MD, medical director for general surgery at Baptist Health South Florida (Miami, USA). “The platform automates what have been manual laparoscopic tasks in meaningful ways with added strength, precision, and visualization. Plus, the platform allows me to scrub in and work at the patient’s side, and maintains a tactile feel that I want as a surgeon.”

Related Links:
TransEnterix